Literature DB >> 1469455

Evaluation of IL-2, sIL2R, IL-6, TNF-alpha, and IL-1 beta levels in serum and CSF of patients with optic neuritis.

M Deckert-Schlüter1, D Schlüter, G Schwendemann.   

Abstract

Optic neuritis (ON) is characterized by immune-mediated demyelination of the optic nerve. In this study we addressed the question of cytokine signalling as part of activation of the immune system. 20 patients with first episode of acute idiopathic unilateral ON, prolonged visual evoked potentials, but normal 1.5 tesla MRI of the brain, and normal somatosensory evoked potentials were included into the study. Paired cerebrospinal fluid (CSF) and serum samples of these patients were analyzed for the presence of interleukin (IL-)-2, soluble IL-2R (sIL2R), IL-6, tumor necrosis factor (TNF)-alpha, and IL-1 beta by an enzyme-linked immunosorbent assay (IL-2, sIL2R, TNF-alpha, IL-1 beta) or a bioassay (IL-6). IL-2 was significantly elevated in the CSF (P < 0.01), whereas sIL2R (P < 0.01) and IL-6 (P < 0.01) were significantly increased in serum. TNF-alpha could not be detected in CSF or serum, and IL-1 beta was negative in serum in all but one sample and positive in only low amount (mean 9 pg/ml) in the CSF of 6/20 patients. This cytokine pattern in ON indicates an activation of the immune system within and outside the central nervous system with a predominance of T-cell activation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1469455     DOI: 10.1016/0022-510x(92)90264-l

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  6 in total

1.  Acute demyelinating disorders of the central nervous system.

Authors:  Meghan K Harris; Amir Hadi Maghzi; Masoud Etemadifar; Roger E Kelley; Eduardo Gonzalez-Toledo; Alireza Minagar
Journal:  Curr Treat Options Neurol       Date:  2009-01       Impact factor: 3.598

2.  Induction of granzyme B and T cell cytotoxic capacity by IL-2 or IL-15 without antigens: multiclonal responses that are extremely lytic if triggered and short-lived after cytokine withdrawal.

Authors:  David L Tamang; Doug Redelman; Bryce N Alves; Leanne Vollger; Christy Bethley; Dorothy Hudig
Journal:  Cytokine       Date:  2006-12-22       Impact factor: 3.861

3.  Optic neuropathy associated with Castleman disease.

Authors:  Ungsoo Kim; Jeong-Min Hwang
Journal:  Korean J Ophthalmol       Date:  2010-08-03

4.  Contribution of TRPV1 to microglia-derived IL-6 and NFkappaB translocation with elevated hydrostatic pressure.

Authors:  Rebecca M Sappington; David J Calkins
Journal:  Invest Ophthalmol Vis Sci       Date:  2008-03-24       Impact factor: 4.799

5.  Comparative analysis of the expression of c-Fos and interleukin-2 proteins in hypothalamus cells during various treatments.

Authors:  S V Barabanova; Z E Artyukhina; K T Ovchinnikova; T V Abramova; T B Kazakova; V Kh Khavinson; V V Malinin; E A Korneva
Journal:  Neurosci Behav Physiol       Date:  2008-03

6.  Astrogliosis is delayed in type 1 interleukin-1 receptor-null mice following a penetrating brain injury.

Authors:  Hsiao-Wen Lin; Anirban Basu; Charles Druckman; Michael Cicchese; J Kyle Krady; Steven W Levison
Journal:  J Neuroinflammation       Date:  2006-06-30       Impact factor: 8.322

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.